A class of drugs designed to fight diabetes and weight loss can help with a host of other problems, but also carry some side effects.

Of late, there have been many questions about maintaining weight loss after using Ozempic (semaglutide) and whether the process kick-started by the drug can be sustainable in the long run. Ozempic works by mimicking a natural hormone called GLP-1,

Read More: Patients Are Suing Over Alleged Side Effects of Weight-Loss Drugs

People who stayed on a 7.2 milligram weekly dose of semaglutide lost around 20% of their body weight over 72 weeks.

Ozempic was first approved to treat diabetes in Canada seven years ago. Now the largest study of its kind suggests it and other medications like it have a host of other potential health benefits beyond obesity,

In one corner, we’ve got Mounjaro, and in the other, Ozempic. They’re both once-a-week injectable drugs designed to help patients with type 2 diabetes manage blood sugar.

Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.

A new study found that GLP-1 medications like Ozempic can lower your risk for 42 conditions, including dementia. Here's what to know, per a neurologist.

The first study to assess how weight-loss drugs affect the whole of human health has discovered an "eye-opening" impact on the body, researchers say. The analysis, involving about two million people,